The Procurement Value in Life Science and the key challenges to efficient execution
The days of rapid growth and high margin levels are no more for the pharmaceutical industry. In order to continue delivering high and attractive profitability ratios, the industry is now faced with the same pressure to achieve excellence in cost optimization facing other industries. Pharmaceutical companies need to gain improved control over their overall cost base and a greater ability to variabilize fixed costs.
The full content of this page is only available to SIG Members.
The days of rapid growth and high margin levels are no more for the pharmaceutical industry. In order to continue delivering high and attractive profitability ratios, the industry is now faced with the same pressure to achieve excellence in cost optimization facing other industries. Pharmaceutical companies need to gain improved control over their overall cost base and a greater ability to variabilize fixed costs.